Geron Corporation operates as a biopharmaceutical company. The company supports the clinical stage development of imetelstat, a telomerase inhibitor for the treatment of hematologic myeloid malignancies. It has collaboration and license agreement with Janssen Biotech, Inc. to develop and commercialize imetelstat worldwide for indications in oncology, including hematologic myeloid malignancies and other human therapeutic uses. The company was founded in 1990 and is based in Menlo Park, California.
This stock seems to want to avoid going sub-$1 right now, looks like there's some possibility to show strength in the 1-hour chart If it gets going up, it could make $1.70 easy, but $2.50 looks like the most it could attain. Might be some fireworks in short term, but not looking like a long-term hold.
